All screening collections in this category were designed to meet the requirements from global scientific research institutions and pharmaceutical companies to help speed up anti-COVID-19 drugs development. The compound libraries contain compounds that have been demonstrated to have anti-coronavirus activity or are broad-spectrum antiviral agents and compounds from virtual screening hits based on molecular docking with high affinity to 7 SARS-CoV-2 protein targets and 1 human ACE2.
Cat No. | product name | ||
---|---|---|---|
L1710 | Anti-COVID-19 Compound Library | A unique collection of 2448 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents; | 2448 compounds |
L1711 | Anti-COVID-19 compound library (CADD) | A unique collection of 362 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 362 compounds |
L1712 | 3CLpro-Targeted compound library (CADD) | A unique collection of 161 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 161 compounds |
L1713 | ACE2-Targeted compound library (CADD) | A unique collection of 462 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 462 compounds |
L1714 | RBD-Targeted compound library (CADD) | A unique collection of 206 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 206 compounds |
L1715 | nsp16-Targeted compound library (CADD) | A unique collection of 281 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 281 compounds |
L1716 | PLpro-Targeted compound library (CADD) | A unique collection of 474 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 474 compounds |
L1717 | RdRP-Targeted compound library (CADD) | A unique collection of 464 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 464 compounds |
L1718 | X Domain-Targeted compound library (CADD) | A unique collection of 463 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 463 compounds |
L1719 | nsp15-Targeted compound library (CADD) | A unique collection of 470 compounds having the potential of anti-SARS-CoV-2 activity, can be used for high throughput screening and high content screening; | 470 compounds |
L6720 | Anti-COVID-19 Traditional Chinese Medicine Compound Library | A unique collection of 389 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening; | 389 compounds |